← All claims

Diets · Metabolic & Cardiometabolic

time-restricted eating improves insulin sensitivity

In plain terms: Does eating earlier in the day improve insulin response?

Leans support Diets 🔬 Includes disconfirming

Part of: 🥗 time-restricted eating

RefutedContestedStrong support
consensus score 0.51

Probably modestly yes, but only from small short trials and the effect doesn't always hold.

📅 Last reviewed: 2026-07-15 ⓘ

Evidence ladder

How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."

Top evidence so far: All trials, pooled (Meta-analysis)

MechanismIn-vitroAnimalObservationalRCTMeta-analysis

How the studies fall

10 support 2 contradict 1 tested null 3 mixed · 16 sources, 11 independent groups

What the evidence shows

Early time-restricted feeding (morning-aligned window) improved insulin sensitivity weight-independently in small supervised trials - the most credible 'timing matters' signal - but it is fragile and not always maintained.

The evidence (21)

SourceGradeStanceQualityFinding
Park J, Kim MS, Boo YK
2026 · Nutrition Reviews
meta-analysis mixed moderate TRE improved several cardiovascular/NAFLD risk markers in overweight adults but effects on insulin endpoints were inconsistent across trials.
Søndergaard AM, Kjærulff MLG, Gormsen LC, Søndergaard E
2026 · American journal of physiology. Cell physiology
observational mixed moderate Mini-review of RCTs/meta-analyses on TRE cardiometabolic effects: modest weight loss vs ad libitum but no consistent benefit vs caloric restriction; effects on glycemic control and insulin sensitivity are 'generally small, variable, and con
Peters B, Schwarz J, Schuppelius B, Ottawa A, Koppold DA, Weber D, Steckhan N, Mai K, Grune T, Pfeiffer AFH, Michalsen A, Kramer A, Pivovarova-Ramich O
2025 · Sci Transl Med
RCT contradicts high Randomized crossover, n=31 women with overweight/obesity, 2-wk eTRE (8:00-16:00) vs 2-wk lTRE (13:00-21:00), intended isocaloric. Insulin sensitivity: between-arm -0.07 (95% CI -0.77 to 0.62); within eTRE 0.31 (-0.14 to 0.76), within lTRE 0.19 (-0.22 to 0.60) - all null. Authors: 'neither eTRE nor lTRE improves insulin sensitivity'. Caveat: 2-wk arms, no habitual-eating control arm, so TRE-vs-baseline is within-arm pre-post; small unintended deficit (eTRE -167 kcal/d).
Liu J, Yi P, Liu F
2023 · J Clin Endocrinol Metab
RCT supports moderate Early TRE produced greater weight loss and metabolic-health gains, including insulin resistance, vs later TRE over the trial period.
Qin Y, Li X, Wang L, Shuang F, Jin X, Qu T, Wang Y, Wu Y, Tian J, Qian Y, Lv Q, Wang Z, Wang Y, Xing Y
2026 · Frontiers in aging
observational supports low n=23 males with metabolic syndrome, 1-month eTRE intervention (same cohort design as companion brain-imaging study); BMI, fasting glucose, and lipid profiles improved (p<0.05); primary endpoints were brain-aging/memory, not insulin sensitiv
Rehman Z, Altonji OM, Steger FL, Jamshed H, Richman JS, Warriner AH, Peterson CM
2026 · J Nutr
RCT mixed moderate Secondary analysis: eTRE benefits on cardiometabolic markers varied by phenotype/age/sex/race, so insulin-sensitivity gains are not uniform.
Alum EU
2025 · Journal of health, population, and nutrition
observational supports low Narrative review (2013-2025 literature) on circadian-aligned eating: cites animal models with isocaloric controls and human trials associating higher energy intake earlier in the day / avoiding late-night eating with improved insulin sensit
Schimenes BC, Alvarenga TA, Tufik SB, Tufik S, Andersen ML
2026 · Frontiers in nutrition
observational mixed moderate Mini narrative review: TRE improves glycemic control/insulin sensitivity in some studies, some effects independent of weight loss, but 'many identified advantages appear to be largely driven by spontaneous caloric restriction' with several
Harvie M, Coe P, Higham C, Peach N, Howell A, Evans DG, Williams S, Sellers K, Malcomson L, Pegington M, Renehan AG
2025 · BMC Nutr
RCT tested-null low RCT: IER insulin-sensitivity gains NOT maintained across normal-eating days
Lu L, Chen X, Liou S, Weng X
2025 · J Health Popul Nutr
meta-analysis supports moderate GRADE-assessed meta-analysis: intermittent fasting improved insulin resistance, lipids and inflammation in metabolic syndrome.
Tric&#xf2; D, Masoni MC, Baldi S, Cimbalo N, Sacchetta L, Scozzaro MT, Nesti G, Mengozzi A, Nesti L, Chiriac&#xf2; M, Natali A
2024 · Diabetologia
RCT tested-null moderate Open-label RCT, n=27 randomised (23 completers) T2D with overweight, 12 wk: early time-restricted carbohydrate consumption (carbs at breakfast/lunch, dinner of protein/fat plus fruit/vegetables, 3 meals/day) vs Mediterranean diet, both with matched energy restriction. Insulin sensitivity (HOMA-IR, Matsuda) 'similarly increased by the diet in both groups'; HbA1c -3 vs -4 mmol/mol (p=0.386). Not a restricted eating window: the eTRC arm ate dinner, so this tests carbohydrate timing, not time-restricted eating.
Wong PS, Wan K, Dai Z, Yu AP, Wong SH, Poon ET
2025 · Nutrition Reviews
meta-analysis supports moderate Meta-analysis of 16/8 TRE: overall improvement in fasting glucose, HOMA-IR, insulin and HDL-C vs comparators.
Jin X, Feng L, Li X, Qu T, Wu Y, Wang Z, Hui K, Guo H, Chen L, Wang L, Wang Y
2026 · Frontiers in nutrition
observational supports low n=21 males with metabolic syndrome, 1-month early time-restricted eating (eTRE) intervention. Fasting insulin and HOMA-IR significantly decreased and QUICKI (insulin-sensitivity index) increased (all p<0.01), alongside weight/BMI/glucose de
Jamshed H, Beyl RA, Della Manna DL, Yang ES, Ravussin E, Peterson CM
2019 · Nutrients
RCT mixed low Crossover n=11: early window lowered 24h glucose, raised autophagy/clock-gene expression
Sutton EF, Beyl R, Early KS, Cefalu WT, Ravussin E, Peterson CM
2018 · Cell Metab
RCT supports low Supervised eucaloric crossover n=8 prediabetic men: 6h early window improved insulin sensitivity & BP (weight held)
Xie Z, Sun Y, Ye Y, Hu D, Zhang H, He Z, Zhao H, Yang H, Mao Y
2022 · Nature Communications
RCT supports moderate In non-obese adults, early TRF improved insulin sensitivity and fasting glucose more than mid-day TRF; eTRF favored over mTRF for insulin resistance.
Wu H, Shi Y, Wang Z, Wei Z, Cui C, Xiong H, Wang Z, Ren J
2025 · Frontiers in medicine
observational supports moderate Narrative review of TRE trials 2015-2025 for healthy aging: reports body-weight and HbA1c improvements (0.3-0.5%) attributable to combined calorie-restriction + timing effects; notes early eating window (eTRE) shows 'relative advantages' du
Khalafi M, Habibi Maleki A, Ghasemi F, Ehsanifar M, Symonds ME, Rosenkranz SK, Tinsley GM, Malek MK, Vakil S, Rafiei H
2026 · Rev Endocr Metab Disord
meta-analysis supports moderate Network meta-analysis: intermittent-fasting types improved glycemic control in adults with overweight/obesity; TRE among effective approaches.
Huang L, Chen Y, Wen S, Lu D, Shen X, Deng H, Xu L
2023 · Food Sci Nutr
meta-analysis supports moderate Meta-analysis of 8/16 TRE: benefits for weight and some metabolism markers but limited/uncertain effect on insulin sensitivity specifically.
Kramer CK, Zinman B, Feig DS, Retnakaran R
2025 · J Clin Endocrinol Metab
RCT supports moderate TRE improved beta-cell function in adults with type 2 diabetes, consistent with better insulin handling.
Zaman A, Grau L, Jeffers R, Steinke S, Catenacci VA, Cornier MA, Rynders CA, Thomas EA
2024 · Obesity Sci Pract
RCT contradicts low Secondary analysis (first 12 wk) of an RCT (NCT03571048): 81 adults with overweight/obesity randomised to early TRE plus daily caloric restriction vs daily caloric restriction alone; HOMA-IR analysable in 38. Weight-adjusted HOMA-IR change: DCR -0.4 (SD 0.7) vs E-TRE+DCR -0.3 (SD 0.6), group x time p=0.666 - a clean null with the point estimate slightly favouring DCR; fasting insulin, glucose, A1c also no difference; MAGE fell more with DCR (p=0.03). Adding an early window to matched caloric restriction did not improve insulin sensitivity. Low baseline insulin resistance (HOMA-IR ~1.6) and 47% data completeness limit sensitivity.

Disagree, or know a study we missed?

We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.

📚 Suggest a study ⚑ Flag / request reclassification

Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).

Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.